Health supplement company BioAlpha Holdings remains an add at CIMB Equities Research as continued strong domestic revenue is a potential catalyst.
KUALA LUMPUR: Health supplement company BioAlpha Holdings remains an add at CIMB Equities Research as continued strong domestic revenue is a potential catalyst.
It said on Friday the 1HFY18 net profit, at 27% of its full-year forecast, was in-line with its expectations as 1H is seasonally the weaker half.
Already a subscriber? Log in.
Get 30% off with our ads free Premium Plan!
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
